Valeant Offers to Buy Botox Maker Allergan

April 22 (Bloomberg) -- Valeant Pharmaceuticals International offered to buy Allergan for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment. Scarlet Fu reports on Bloomberg Television’s “Bloomberg Surveillance.” (Source: Bloomberg)
Nigerian Tensions Rise as Nation Awaits Election Results
43:41 - Nigerians await results of a contentious election as the main opposition party alleged the vote was rigged. Bloomberg’s Uche Okoronkwo reports on “The Pulse.” (Source: Bloomberg)
  • Iran Oil Supplies to Prevent Price Recovery: Ashok Shah
  • Greece’s Situation Is as Dire as It Can Get: Ashok Shah
  • Can Nigerian Elections Help Spur Investment?